Crosstalk between glia, extracellular matrix and neurons.

Area of Science:

• Neuroscience
• Cell Biology
• Biochemistry

Background:

• Extracellular matrix (ECM) molecules are crucial for central nervous system (CNS) development and function.
• Key ECM components include chondroitin sulfate proteoglycans (CSPGs), tenascin-R, and hyaluronic acid, synthesized by neurons and glia.
• ECM expression is dynamically regulated during development and in response to CNS injury, aging, and neurodegeneration.

Purpose of the Study:

• To review the multifaceted roles of neural ECM in CNS development, plasticity, and repair.
• To explore the dual nature of ECM, presenting both growth-inhibitory and neuroprotective effects.
• To highlight the therapeutic potential of targeting ECM molecules and their degrading enzymes.

Main Methods:

• Literature review of studies on neural ECM composition, synthesis, and function.
• Analysis of ECM's role in development, synaptic plasticity, and axonal regeneration.
• Investigation of ECM's involvement in CNS injury, aging, and neurodegenerative diseases.

Main Results:

• ECM structures are vital for guiding cell migration, neurite outgrowth, and synaptogenesis.
• ECM regulates synaptic plasticity, cognitive flexibility, and axonal regeneration.
• Upregulation of ECM, particularly CSPGs by reactive astrocytes, can impair plasticity and regeneration, but ECM also forms neuroprotective perineuronal nets.

Conclusions:

• Neural ECM plays critical roles in CNS development, plasticity, and repair.
• Dysregulation of ECM contributes to impaired regeneration and synaptic plasticity in various CNS disorders.
• Targeting ECM molecules, associated glycans, and degrading enzymes (MMPs, ADAMTS) presents promising therapeutic strategies for CNS regeneration and plasticity.